oncoqr.com oncoqr.com

ONCOQR.COM

Biotech start-up that develops cancer immunotherapies | OncoQR ML

Our vision is to defeat cancer. Our aim is to fully arm the patient’s immune system to successfully fight and thus win the battle against cancer.

http://www.oncoqr.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR ONCOQR.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 11 reviews
5 star
1
4 star
6
3 star
4
2 star
0
1 star
0

Hey there! Start your review of oncoqr.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

2.2 seconds

FAVICON PREVIEW

  • oncoqr.com

    16x16

  • oncoqr.com

    32x32

CONTACTS AT ONCOQR.COM

OncoQR-ML

Christof Langer

Walte●●●●●se 21

Tull●●●●bach , 3011

AT

43.6●●●●0032
f4●●●●●●●●●@opensrs.namespace4you.com

View this contact

OncoQR-ML

Christof Langer

Walte●●●●●se 21

Tull●●●●bach , 3011

AT

43.6●●●●0032
f4●●●●●●●●●@opensrs.namespace4you.com

View this contact

Domainfactory GmbH

Hostmaster Domainfactory

Oskar-M●●●●●●●Str. 33

Ism●●●ing , 85737

DE

49.8●●●●2660
op●●●●●@namespace4you.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2012 October 19
UPDATED
2014 April 26
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 12

    YEARS

  • 8

    MONTHS

  • 21

    DAYS

NAME SERVERS

1
ns.namespace4you.com
2
ns2.namespace4you.com

REGISTRAR

TUCOWS DOMAINS INC.

TUCOWS DOMAINS INC.

WHOIS : whois.tucows.com

REFERRED : http://domainhelp.opensrs.net

CONTENT

SCORE

6.2

PAGE TITLE
Biotech start-up that develops cancer immunotherapies | OncoQR ML | oncoqr.com Reviews
<META>
DESCRIPTION
Our vision is to defeat cancer. Our aim is to fully arm the patient’s immune system to successfully fight and thus win the battle against cancer.
<META>
KEYWORDS
1 vision
2 about us
3 company profile
4 management board
5 scientific advisory committee
6 grants
7 technology
8 cancer immunotherapy
9 mode of action
10 therapeutic principle
CONTENT
Page content here
KEYWORDS ON
PAGE
vision,about us,company profile,management board,scientific advisory committee,grants,technology,cancer immunotherapy,mode of action,therapeutic principle,pipeline,partnering,news,close,join our forces,in defeating cancer,about oncoqr ml,meet the team
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Biotech start-up that develops cancer immunotherapies | OncoQR ML | oncoqr.com Reviews

https://oncoqr.com

Our vision is to defeat cancer. Our aim is to fully arm the patient’s immune system to successfully fight and thus win the battle against cancer.

INTERNAL PAGES

oncoqr.com oncoqr.com
1

products

http://oncoqr.com/products/products.html

R100 - out licensed to TYG-Oncology Ltd.). 100 fold higher anti-G17 IgG titres in almost 100% of the patients, thereby enabling an early regulatory approval pathway with a pivotal Phase II trial. An International Multicenter Randomized Controlled Trial of G17DT in Patients With PDAC”, Gilliam A.D. et al, Pancreas 2011 www.pancreasjournal.com Rapid induction (. Immune response to a clinically validated target: Her2. Interim analysis of ongoing study shows. PoC in non human primates achieved in April 2015.

2

company

http://oncoqr.com/company/company.html

R) is a biotech start-up that develops novel, adjustable cancer immunotherapies (ACIs) to treat oncologic diseases. OQR’s ACIs are based on the unique, proprietary human specific S-TIR™ technology platform, which enables the patient’s immune system to generate a powerful immune response against tumor associated antigens. Lead candidate #1., O.

3

advisory board

http://oncoqr.com/company/advisory_board/advisory_board.html

Prof Dr. Jolanda de Vries – Radboud University, Nijmegen, the Netherlands – Prof. of Tumor Immunology; expert in plasmacytoid dendritic cells. Prof Dr. Reingard Grabherr – University of Agricultural Sciences, Vienna, Austria – Prof. of Biotechnology; expert in protein engineering. Dr Gottfried Himmler – Co-founder and previous CEO of f-star GmbH.

4

grants

http://oncoqr.com/company/grants/grants.html

Although founded only in 2013,. So far received 3 grants for its work in the area of anti-cancer development:. A start-up grant in 2014 provided by Accent, the governmental incubator of lower Austria. A Start-up grant received in 2014 by FFG - the Austrian Research Promotion Agency - for development of its second cancer therapy, O. R200, directed to improve patients lives diagnosed breast cancer.

5

disclamer

http://oncoqr.com/company/disclamer/disclamer.html

Uses all reasonable efforts to provide up-to-date, complete and correct information on these websites. It does not make any representations or warranties with regard to the contents provided on these websites such as hyperlinks or other contents available, directly or indirectly, on these websites. Assumes no responsibility or liability which may, in any form whatsoever be construed from the use of these websites or related thereto. Thus,. Assumes no responsibility and. Does not have control over other w...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

OTHER SITES

oncopy.ru oncopy.ru

Заправка картриджей в Москве с выездом: недорого, качественно и быстро. Компания Oncopy.

Хотите заправить свои картриджи быстро, качественно, надёжно и при этом недорого? Или сделать онлайн заказ на нашем сайте. Заправка картриджа HP CE285A (85A) для HP LaserJet P1102w/M1132 mfp/M1212nf/M1214nfh/M1217nfw. Заправка картриджа Brother TN-2075 для DCP-7010R, MFC-7420R и HL-2030R. Заправка картриджа HP Q2612A (12A) для LaserJet 1010/1018/1020/1022/3050/3055/M1005/M1319. Заправка картриджа HP CB436A (36A) для LaserJet P1505/M1120 и M1522. Заправка картриджа Canon 712 для i-sensys LBP-3010/3100.

oncopyright2010.com oncopyright2010.com

OnCopyright 2010: The Collision of Ideas

Follow the latest conference updates at. In this Beyond the Book interview. With conference producer Bill Burger. Senior VP and Deputy General Counsel. Warner Bros. Entertainment. John F. Nickoll Professor of Law. VP, General Counsel and Secretary. March 10th, 2010. The Union League Club, NYC.

oncopyright2012.com oncopyright2012.com

OnCopyright 2012: Advancing the Creative Economy

March 30, 2012, Columbia Law School, NYC. Advancing the Creative Economy. Enjoy the post-event commentary from our panelists:. Watch clips of panels and presenters on UStream. Author and journalist Robert Levine's presentation and listen to Beyond the Book podcasts. Check out the media coverage:. Publishing Trends: "Prospering in the Creative Economy". PaidContent: "Time to move beyond 'sharing' and 'stealing". Digital Book World: ".Creative Economy will continue to grow.".

oncopyright2014.com oncopyright2014.com

OnCopyright 2014: April 2, New York, NY

APRIL 2, 2014, NEW YORK, NY. Venue – NYAS. Wednesday, April 2, 2014 at The New York Academy of Sciences. On our UStream channel. Enjoy the post-event commentary from our panelists:. Listen to the Beyond the Book interview. With event host Robert Levine. Previously executive editor of Billboard Magazine, Levine has written for. The New York Times. As he researched and wrote.

oncoqol.mobi oncoqol.mobi

Site Unavailable

This site is currently unavailable.

oncoqr.com oncoqr.com

Biotech start-up that develops cancer immunotherapies | OncoQR ML

Geert Mudde, CSO. Our aim is to fully arm the patient’s immune system to fight and win the battle against cancer. Our proprietary S-TIR Platform. Is available for licensing on a target-by-target basis.". Christof Langer, CEO. Our Active Checkpoint Control. Immunotherapy (ACCI) is capable of activating all 4 naturally available and evolutionary perfected tumor killing mechanisms in parallel. Liesbeth Mudde-Boer, Scientist. Lets join forces to win the fight against cancer! OncoQR ML was founded by two expe...

oncoqualitycare.com oncoqualitycare.com

Onco Quality Care - Empresa-OQC

Jueves, 12 Abril 2018. Dr Javier Kelly / Cirujano Oncólogo / Quimioterapeuta / Sub-Especialidad en Tórax Oncología Tórax (mama, pulmón). Onco Quality Care, es un. CENTRO ESPECIALIZADO EN SERVICIOS INTEGRALES ONCOLOGICOS. A bajo costo. Garantizando la oportuna y eficiente atención a pacientes con cáncer. Calidad de Vida: Proveer el tratamiento que permita a cada paciente tener la mejor calidad y sobrevida posible. Flexibilidad: En aquellos casos donde el paciente requiera de una atención especial. Juegos ...

oncoque.fr oncoque.fr

Coques Telephone Portable Housse Etui et Film - Oncoque.fr

Panier Produit: ( 0. Apple iPhone 6 Plus. Apple iPod Touch 5. Apple iPod Touch 4. Apple iPad Air 2. Apple iPad Mini 3. Apple iPad Mini 2. Huawei Ascend P8 MAX. Huawei Ascend P8 Lite. Huawei Honor 6 Plus. Huawei Ascend Mate 7. Huawei Ascend Mate 2. Huawei Mediapad Honor X2. Huawei Honor 3 Outdoor. Huawei Ascend W1 Windows Phone. Huawei Honor 2 U9508. Huawei Ascend P1 U9200. Huawei Ascend G510 U8951D. Huawei Ascend G600 U8950D. Huawei Ascend Y300 U8833. Ascend G330C G330D U8825D. Ascend G300 U8815 U8818.

oncoquest.com oncoquest.com

OnCoQuest

OnCoQuest is a recently established, international society for requesting contemporary oncology expert reviews of cancer patient-cases internationally.

oncoquest.org oncoquest.org

OnCoQuest

OnCoQuest is a recently established, international society for requesting contemporary oncology expert reviews of cancer patient-cases internationally.

oncoquestinc.com oncoquestinc.com

OncoQuest Inc.

Scientific Clinical Advisory Board. Anti-PSA Prostate Cancer Program (IgG and IgE). OncoQuest, in partnership with a China-based global. Pharmaceutical company, has launched a new venture in the. Edmonton Journal Article, December 8, 2016. December 7, 2016. OncoQuest Initiates Commercial Scale Oregovomab Manufacturing Program for Treatment of Ovarian Cancer. November 29, 2016. OncoQuest Announces Positive Interim Results from Its Phase 2b Clinical Study. Website Design by Primal Tribe.